SLC25A20 and neoplasm: Immunohistochemical staining showed a significant increase of SLC25A20 expression in xenografts developed from SLC25A20 overexpression (SLC25A20) group compared with the empty vector (EV) group (Fig. 4C), suggesting that the tumor-suppressive effect was exerted by SLC25A20 overexpression.